Technical Analysis for TWST - Twist Bioscience Corporation
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 31.54 | 1.48% | 0.46 |
TWST closed up 1.48 percent on Friday, April 26, 2024, on 80 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: May 2
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Crossed Above 20 DMA | Bullish | 0.00% | |
NR7 | Range Contraction | 0.00% | |
Multiple of Ten Bullish | Other | 1.48% | |
Gapped Down | Weakness | 1.48% | |
20 DMA Resistance | Bearish | 2.57% | |
Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 2.57% | |
MACD Bullish Signal Line Cross | Bullish | 2.57% | |
Inside Day | Range Contraction | 2.57% | |
20 DMA Resistance | Bearish | 0.13% | |
Multiple of Ten Bullish | Other | 0.13% |
Alert | Time |
---|---|
Possible NR7 | about 18 hours ago |
60 Minute Opening Range Breakout | about 18 hours ago |
Up 2% | about 18 hours ago |
20 DMA Resistance | about 21 hours ago |
Up 1% | about 22 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/02/2024
We are a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next generation sample (NGS) preparation, and antibody libraries for drug discovery and development. We are also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. We make products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Drug Discovery Genomics Genetic Engineering Industrial Chemical Synthetic Biology Molecular Genetics Dna Synthesis Silicon Chip
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Biotechnology Biopharmaceutical Life Sciences Biology Emerging Technologies Drug Discovery Genomics Genetic Engineering Industrial Chemical Synthetic Biology Molecular Genetics Dna Synthesis Silicon Chip
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 43.21 |
52 Week Low | 11.46 |
Average Volume | 809,194 |
200-Day Moving Average | 27.62 |
50-Day Moving Average | 34.72 |
20-Day Moving Average | 31.21 |
10-Day Moving Average | 29.71 |
Average True Range | 1.70 |
RSI (14) | 48.45 |
ADX | 18.0 |
+DI | 21.34 |
-DI | 24.65 |
Chandelier Exit (Long, 3 ATRs) | 30.00 |
Chandelier Exit (Short, 3 ATRs) | 32.50 |
Upper Bollinger Bands | 35.02 |
Lower Bollinger Band | 27.41 |
Percent B (%b) | 0.54 |
BandWidth | 24.39 |
MACD Line | -1.12 |
MACD Signal Line | -1.41 |
MACD Histogram | 0.2954 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 32.95 | ||||
Resistance 3 (R3) | 32.85 | 32.28 | 32.72 | ||
Resistance 2 (R2) | 32.28 | 31.92 | 32.33 | 32.64 | |
Resistance 1 (R1) | 31.91 | 31.70 | 32.10 | 32.01 | 32.56 |
Pivot Point | 31.34 | 31.34 | 31.43 | 31.39 | 31.34 |
Support 1 (S1) | 30.97 | 30.98 | 31.16 | 31.07 | 30.52 |
Support 2 (S2) | 30.40 | 30.76 | 30.45 | 30.44 | |
Support 3 (S3) | 30.03 | 30.40 | 30.37 | ||
Support 4 (S4) | 30.13 |